DEA To Announce Hearing on Proposed Marijuana Rescheduling

Who says nothing happens in Washington, D.C., in August?  The Drug Enforcement Administration (“DEA”) will announce Thursday in the Federal Register that it will hold a hearing on the proposed rescheduling of marijuana to schedule III at DEA Headquarters in Arlington, Virginia on December 2, 2024.  DEA received over 43,500 public comments in response to the agency’s Notice of Proposed Rulemaking in the Federal Register on May 21, 2024.

“Interested persons,” that is “any person adversely affected or aggrieved by any rule or proposed rule issuable” under the Controlled Substances Act wishing to participate in the hearing must file a written notice of their intention to participate, which DEA will review.

Each notice of intention to participate must:

1. State with particularity the interest of the person in the proceeding;
2. State with particularity the objections or issues concerning which the person desires to be heard; and
3. State briefly the position of the person regarding the objection or issues.

Interested persons can file electronically as a PDF attachment via email to the Drug Enforcement Administration, Attn: Administrator at nprm@dea.gov or in writing to the Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, VA 22152 within 30 days after publication in the Federal Register.

As we said in our earlier post when DEA announced initiation of the rescheduling proposal in May, “buckle up!”